These include hepatic Insr down-regulation, reduced insulin signaling and development of insulin resistance [96], impaired glucose tolerance, BW gain, dyslipidemia, liver fat accumulation and increased risk of NAFLD/NASH [15, 97]. Here, INS is linked to metabolic syndrome.